Chapter/Section Purchase

1 Study Coverage
1.1 Equine Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Equine Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liquid
1.2.3 Powder
1.3 Market by Application
1.3.1 Global Equine Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Home
1.3.3 Pet Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Equine Influenza Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Equine Influenza Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Equine Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Equine Influenza Vaccine Sales by Region
2.4.1 Global Equine Influenza Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Equine Influenza Vaccine by Region (2023-2028)
2.5 Global Equine Influenza Vaccine Revenue by Region
2.5.1 Global Equine Influenza Vaccine Revenue by Region (2017-2022)
2.5.2 Global Equine Influenza Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Equine Influenza Vaccine Sales by Manufacturers
3.1.1 Global Top Equine Influenza Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Equine Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Equine Influenza Vaccine in 2021
3.2 Global Equine Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Equine Influenza Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Equine Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Equine Influenza Vaccine Revenue in 2021
3.3 Global Equine Influenza Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Equine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Equine Influenza Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Equine Influenza Vaccine Sales by Type
4.1.1 Global Equine Influenza Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Equine Influenza Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Equine Influenza Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Equine Influenza Vaccine Revenue by Type
4.2.1 Global Equine Influenza Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Equine Influenza Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Equine Influenza Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Equine Influenza Vaccine Price by Type
4.3.1 Global Equine Influenza Vaccine Price by Type (2017-2022)
4.3.2 Global Equine Influenza Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Equine Influenza Vaccine Sales by Application
5.1.1 Global Equine Influenza Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Equine Influenza Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Equine Influenza Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Equine Influenza Vaccine Revenue by Application
5.2.1 Global Equine Influenza Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Equine Influenza Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Equine Influenza Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Equine Influenza Vaccine Price by Application
5.3.1 Global Equine Influenza Vaccine Price by Application (2017-2022)
5.3.2 Global Equine Influenza Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Equine Influenza Vaccine Market Size by Type
6.1.1 North America Equine Influenza Vaccine Sales by Type (2017-2028)
6.1.2 North America Equine Influenza Vaccine Revenue by Type (2017-2028)
6.2 North America Equine Influenza Vaccine Market Size by Application
6.2.1 North America Equine Influenza Vaccine Sales by Application (2017-2028)
6.2.2 North America Equine Influenza Vaccine Revenue by Application (2017-2028)
6.3 North America Equine Influenza Vaccine Market Size by Country
6.3.1 North America Equine Influenza Vaccine Sales by Country (2017-2028)
6.3.2 North America Equine Influenza Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Equine Influenza Vaccine Market Size by Type
7.1.1 Europe Equine Influenza Vaccine Sales by Type (2017-2028)
7.1.2 Europe Equine Influenza Vaccine Revenue by Type (2017-2028)
7.2 Europe Equine Influenza Vaccine Market Size by Application
7.2.1 Europe Equine Influenza Vaccine Sales by Application (2017-2028)
7.2.2 Europe Equine Influenza Vaccine Revenue by Application (2017-2028)
7.3 Europe Equine Influenza Vaccine Market Size by Country
7.3.1 Europe Equine Influenza Vaccine Sales by Country (2017-2028)
7.3.2 Europe Equine Influenza Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Equine Influenza Vaccine Market Size by Type
8.1.1 Asia Pacific Equine Influenza Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Equine Influenza Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Equine Influenza Vaccine Market Size by Application
8.2.1 Asia Pacific Equine Influenza Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Equine Influenza Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Equine Influenza Vaccine Market Size by Region
8.3.1 Asia Pacific Equine Influenza Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Equine Influenza Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Equine Influenza Vaccine Market Size by Type
9.1.1 Latin America Equine Influenza Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Equine Influenza Vaccine Revenue by Type (2017-2028)
9.2 Latin America Equine Influenza Vaccine Market Size by Application
9.2.1 Latin America Equine Influenza Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Equine Influenza Vaccine Revenue by Application (2017-2028)
9.3 Latin America Equine Influenza Vaccine Market Size by Country
9.3.1 Latin America Equine Influenza Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Equine Influenza Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Equine Influenza Vaccine Market Size by Type
10.1.1 Middle East and Africa Equine Influenza Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Equine Influenza Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Equine Influenza Vaccine Market Size by Application
10.2.1 Middle East and Africa Equine Influenza Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Equine Influenza Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Equine Influenza Vaccine Market Size by Country
10.3.1 Middle East and Africa Equine Influenza Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Equine Influenza Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Overview
11.1.3 Zoetis Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Zoetis Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zoetis Recent Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Corporation Information
11.2.2 Merck Animal Health Overview
11.2.3 Merck Animal Health Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Animal Health Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Animal Health Recent Developments
11.3 Boehringer Ingelheim Vetmedica
11.3.1 Boehringer Ingelheim Vetmedica Corporation Information
11.3.2 Boehringer Ingelheim Vetmedica Overview
11.3.3 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Vetmedica Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Equine Influenza Vaccine Industry Chain Analysis
12.2 Equine Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Equine Influenza Vaccine Production Mode & Process
12.4 Equine Influenza Vaccine Sales and Marketing
12.4.1 Equine Influenza Vaccine Sales Channels
12.4.2 Equine Influenza Vaccine Distributors
12.5 Equine Influenza Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Equine Influenza Vaccine Industry Trends
13.2 Equine Influenza Vaccine Market Drivers
13.3 Equine Influenza Vaccine Market Challenges
13.4 Equine Influenza Vaccine Market Restraints
14 Key Findings in The Global Equine Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer